Brandsma D - Search Results

1

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.

Taal W, Oosterkamp HM, Walenkamp AM, Dubbink HJ, Beerepoot LV, Hanse MC, Buter J, Honkoop AH, Boerman D, de Vos FY, Dinjens WN, Enting RH, Taphoorn MJ, van den Berkmortel FW, Jansen RL, Brandsma D, Bromberg JE, van Heuvel I, Vernhout RM, van der Holt B, van den Bent MJ. Taal W, et al. Among authors: brandsma d. Lancet Oncol. 2014 Aug;15(9):943-53. doi: 10.1016/S1470-2045(14)70314-6. Epub 2014 Jul 15. Lancet Oncol. 2014. PMID: 25035291 Clinical Trial.

2

Photo quiz: a cerebral contrast enhancing lesion in a patient with impaired cellular immunity.

Brandsma D, Schurink CA, Bromberg JE. Brandsma D, et al. Neth J Med. 2001 Sep;59(3):95-7. doi: 10.1016/s0300-2977(01)00142-5. Neth J Med. 2001. PMID: 11583823 No abstract available.

3

Multiple cysts in the cerebral white matter: a rare complication of whole brain radiation therapy.

Brandsma D, van Helvoirt R, Taphoorn MJ. Brandsma D, et al. J Neurooncol. 2001 May;53(1):51-4. doi: 10.1023/a:1011870013044. J Neurooncol. 2001. PMID: 11678431

4

Vascular cell adhesion molecule-1 is a key adhesion molecule in melanoma cell adhesion to the leptomeninges.

Brandsma D, Reijneveld JC, Taphoorn MJ, de Boer HC, Gebbink MF, Ulfman LH, Zwaginga JJ, Voest EE. Brandsma D, et al. Lab Invest. 2002 Nov;82(11):1493-502. doi: 10.1097/01.lab.0000036876.08970.c1. Lab Invest. 2002. PMID: 12429809 Free article.

5

The diagnostic difficulties of meningeal and intracerebral plasma cell granulomas--presentation of three cases.

Brandsma D, Jansen GH, Spliet W, Van Nielen K, Taphoorn MJ. Brandsma D, et al. J Neurol. 2003 Nov;250(11):1302-6. doi: 10.1007/s00415-003-0200-7. J Neurol. 2003. PMID: 14648145

6

MR imaging of mouse leptomeningeal metastases.

Brandsma D, Taphoorn MJ, Reijneveld JC, Nas TM, Voest EE, Nicolay K, Blezer E. Brandsma D, et al. J Neurooncol. 2004 Jun;68(2):123-30. doi: 10.1023/b:neon.0000027742.78828.99. J Neurooncol. 2004. PMID: 15218948

7

CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases.

Reijneveld JC, Brandsma D, Boogerd W, Bonfrer JG, Kalmijn S, Voest EE, Geurts-Moespot A, Visser MC, Taphoorn MJ. Reijneveld JC, et al. Among authors: brandsma d. Neurology. 2005 Oct 11;65(7):1120-2. doi: 10.1212/01.wnl.0000178981.39984.c2. Neurology. 2005. PMID: 16217072

8

Interleukin-8 CSF levels predict survival in patients with leptomeningeal metastases.

Brandsma D, Taphoorn MJ, de Jager W, Bonfrer H, Algra A, Reijneveld JC, Boogerd W, Korse T, Verbeek MM, Rijkers GT, Voest EE. Brandsma D, et al. Neurology. 2006 Jan 24;66(2):243-6. doi: 10.1212/01.wnl.0000194239.74384.57. Neurology. 2006. PMID: 16434663

9

Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases.

Brandsma D, Ulfman L, Reijneveld JC, Bracke M, Taphoorn MJ, Zwaginga JJ, Gebbink MF, de Boer H, Koenderman L, Voest EE. Brandsma D, et al. Neuro Oncol. 2006 Apr;8(2):127-36. doi: 10.1215/15228517-2005-013. Epub 2006 Mar 13. Neuro Oncol. 2006. PMID: 16533879 Free PMC article.

10

CSF protein profiling using Multiplex Immuno-assay: A potential new diagnostic tool for leptomeningeal metastases.

Brandsma D, Voest EE, de Jager W, Bonfrer H, Algra A, Boogerd W, Korse T, Reijneveld JC, Verbeek MM, Rijkers G, Taphoorn MJ. Brandsma D, et al. J Neurol. 2006 Sep;253(9):1177-84. doi: 10.1007/s00415-006-0187-y. Epub 2006 Sep 22. J Neurol. 2006. PMID: 16998648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page